Product NDC: | 65862-535 |
Proprietary Name: | Amoxicillin and Clavulanate Potassium |
Non Proprietary Name: | Amoxicillin and Clavulanate Potassium |
Active Ingredient(s): | 600; 42.9 mg/5mL; mg/5mL & nbsp; Amoxicillin and Clavulanate Potassium |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-535 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA201091 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111220 |
Package NDC: | 65862-535-02 |
Package Description: | 200 mL in 1 BOTTLE (65862-535-02) |
NDC Code | 65862-535-02 |
Proprietary Name | Amoxicillin and Clavulanate Potassium |
Package Description | 200 mL in 1 BOTTLE (65862-535-02) |
Product NDC | 65862-535 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Amoxicillin and Clavulanate Potassium |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20111220 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | AMOXICILLIN; CLAVULANATE POTASSIUM |
Strength Number | 600; 42.9 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |